Free Trial

Elekta AB (publ) (OTCMKTS:EKTAY) Sees Large Growth in Short Interest

Elekta AB (publ) logo with Medical background
Remove Ads

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) saw a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 400 shares, an increase of 300.0% from the February 28th total of 100 shares. Based on an average daily trading volume, of 22,500 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company's shares are short sold.

Analyst Upgrades and Downgrades

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a research note on Wednesday, January 29th.

Get Our Latest Research Report on EKTAY

Elekta AB (publ) Trading Down 0.7 %

Shares of OTCMKTS:EKTAY traded down $0.04 during midday trading on Monday, reaching $5.34. The company's stock had a trading volume of 16,185 shares, compared to its average volume of 9,649. Elekta AB has a fifty-two week low of $5.25 and a fifty-two week high of $8.24. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.81 and a current ratio of 1.05. The firm has a 50 day moving average price of $5.75 and a two-hundred day moving average price of $5.93. The firm has a market capitalization of $2.05 billion, a price-to-earnings ratio of 21.35 and a beta of 1.25.

Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last issued its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.01). The business had revenue of $416.86 million during the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. As a group, analysts forecast that Elekta AB will post 0.36 earnings per share for the current year.

Remove Ads

Elekta AB (publ) Cuts Dividend

The business also recently declared a dividend, which was paid on Thursday, March 27th. Shareholders of record on Friday, March 7th were issued a $0.1072 dividend. The ex-dividend date was Friday, March 7th. Elekta AB (publ)'s payout ratio is 44.00%.

Elekta AB (publ) Company Profile

(Get Free Report)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

Featured Articles

Should You Invest $1,000 in Elekta AB (publ) Right Now?

Before you consider Elekta AB (publ), you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.

While Elekta AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads